EM, erythema multiforme; BP, bullous pemphigoid; DEJ, dermal-epidermal junction; DIF, direct immunofluorescence; C3, complement 3; SJS, Stevens-Johnson syndrome.

Table 3. Summary of patient demographics, associated immunotherapy class, rash characteristics, and other irAEs